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1. Introduction 
 
Industrial biotechnology is paving the way for a bio-based 
economy, which is proposed to complement and, in the long term, 
replace petro-based economy. Microorganisms are central to this 
technology and carry out the production reactions whether 
fermentation, whole-cell biocatalysis or enzymatic reactions. Although 
microbial processes have been known and used since many thousands 
years, it is the recombinant DNA technology and more recently the 
application of ‘omics’ technologies that allowed scientists to rationally 
engineer these microbial factories as never before.  
Corynebacterium glutamicum is a Gram-positive bacterium and is 
referred to as the industrial workhorse for amino acid production. It 
was first isolated in 1950s from Japanese soil during a quest for 
natural L-glutamate producers [1]. Since then it has been thoroughly 
investigated and used as a generally-regarded-as-safe (GRAS) 
organism in fermentation industry for more than 50 years. Today it 
is used for the annual production of 2,160,000 tons of L-glutamate 
[2] and 1,480,000 tons of L-lysine [3]. After genetic engineering 
tools were developed, C. glutamicum genome was sequenced and 
made publically available in 2003 [4,5] and omics technologies such 
as transcriptome studies evolved [6]. These milestones marked the 
beginning of extensive research efforts to metabolically engineer C. 
glutamicum, initially for L-glutamate and L-lysine production and 
later on for the production of a variety of products such as organic 
acids, alcohols or diamines. Similarly, use of alternative carbon 
sources, that unlike the traditional sugars sucrose, glucose and 
fructose, do not have competing applications in food industry, 
became possible by metabolic engineering. 
 
 
 
 
 
 
 
 
 
 
 The following pages are intended to provide the reader with a 
glimpse into metabolic engineering of C. glutamicum for (i) 
utilization of alternative carbon sources and (ii) formation of non-
traditional products. Metabolic engineering approaches for L-
glutamate and L-lysine production have been reviewed and 
monographed extensively [7-12], and therefore will not be a part of 
this review. 
 
II. Metabolic engineering for carbon source utilization 
 
 
C. glutamicum can utilize many carbon sources for its growth and 
energy supply: monosaccharides such as glucose, fructose, and ribose; 
disaccharides such as sucrose, mannose, and maltose; alcohols such as 
inositol or ethanol and organic acids such as pyruvic acid, propionic 
acid, lactic acid, acetic acid, and gluconic acid, but also some amino 
acids such as L-glutamate and L-glutamine [13,14]. Production 
processes with C. glutamicum are carried out utilizing sugars derived 
from starch (glucose) or molasses (sucrose and fructose) [8,12]. Use 
of molasses dominates in European, South American and Asian 
production plants, whereas starch hydrolysates are favored in North 
America [12]. In C. glutamicum these sugars are substrates of the 
phosphotransferase system (PTS), which phosphorylates its substrate 
by utilizing phosphoenolpyruvate [15]. 
 
The utilization of glucose via the PTS was increased by 
constitutive expression of the glucose specific EII subunit gene ptsG 
[16]. Furthermore, a PTS-independent glucose utilization pathway, 
which transports glucose into the cell and then phosphorylates it 
using ATP and/or polyphosphate dependent glucokinases [17,18] 
was shown to be present in C. glutamicum. When glucose was solely 
utilized via this system, increased L-lysine production was observed, 
probably due to a higher availability of the L-lysine precursor 
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phosphoenolpyruvate [19,20]. This alternative pathway might be 
favorable for a variety of production processes [21].  
 
Lactic acid is not only the predominant byproduct of C. 
glutamicum during growth with glucose under oxygen limiting 
conditions, but also an interesting carbon source taking its abundance 
in silages into account. C. glutamicum possesses two lactate 
dehydrogenases for the utilization of lactic acids, one specific for L- 
and one for D-lactic acid oxidization to pyruvate [22,23]. The 
quinone-dependent L-lactate dehydrogenase gene (lldD) is 
sufficiently expressed for fast growth with L-lactic acid whereas D-
lactate dehydrogenase gene (dld) needs to be overexpressed for 
efficient D-lactic acid utilization [22-24]. Further strain optimization 
by overexpression of either malic enzyme or pyruvate carboxylase 
genes enabled L-lysine production from lactic acid [24]. The recent 
observation that overexpression of the lactic acid forming NAD-
dependent lactate dehydrogenase gene (ldhA) rescued an lldD 
knockout strain [25] indicates that ldhA overexpression might prove 
beneficial to accelerate lactate catabolism.  
 
Several cheaply available and therefore interesting carbon sources 
cannot be utilized by C. glutamicum, either because the whole or part 
of the necessary genetic setup is missing or a sufficient level of gene 
expression is not present. Thus, the construction of recombinant 
strains towards utilization of further carbon sources is an important 
part of the metabolic engineering of this bacterium.  
 
Glucose derived from starch hydrolysates is used in industrial 
amino acid production processes. In first engineering approaches 
towards direct utilization of starch the -amylase gene from 
Streptomyces griseus was expressed in C. glutamicum and the enzyme 
was excreted into the medium [26]. The recombinant strain was able 
to grow with starch even faster as compared to glucose. However 
growth was only achieved when small amounts of glucose were 
present, and some starch degradation product remained in the 
medium [26]. Expression of the Streptococcus bovis -amylase gene 
together with Bacillus subtilis pgsA to produce a surface displayed 
fusion protein, enabled C. glutamicum for the utilization of starch as 
sole source of carbon [27]. Starch-based production of L-glutamate 
[28], L-lysine [26,27,29], and cadaverine [30] has been reported and 
in the case of L-lysine, higher L-lysine production yields were reached 
with starch as compared to glucose [27].  
 
Utilization of the whey sugars lactose and galactose has been 
engineered in C. glutamicum. Lactose utilization was achieved by 
heterologous expression of the lac genes from Escherichia coli [31]. 
As lactose was cleaved into its monomeric compounds glucose and 
galactose by -galactosidase, C. glutamicum was able to utilize 
liberated glucose but not the galactose component of lactose [31]. 
Combining heterologous expression of the lactose permease and -
galactosidase genes from Lactobacillus delbrueckii with expression of 
Lactococcus lactis subsp. cremoris MG1363 genes for aldose-1-
epimerase, galactokinase, UDP-glucose-1-P-uridylyltransferase, and 
UDP-galactose-4-epimerase allowed the use of both the glucose and 
galactose components of lactose [32]. Whey-based L-lysine 
production was possible, but growth from the whey components was 
slower as compared to that on glucose [32]. 
 
II.2.3 Arabinose  
Arabinose is one of the main compounds of lignocellulosic 
wastes, which accrue from e.g. agricultural or forestry productions. 
Three enzymatic reactions are necessary for the conversion of 
arabinose to the pentose phosphate pathway intermediate xylulose-5-
phosphate: first arabinose isomerase (AraA) converts arabinose to 
ribulose, second ribulokinase (AraB) phosphorylates ribulose to 
ribulose-5-phosphate, which finally is converted to xylulose-5-
phosphate by ribulose-5-phosphate 4-epimerase (AraD) [33]. 
Expression of the arabinose transporter gene araE from C. 
glutamicum ATCC 31831 allowed utilization of at low 
concentrations of arabinose [34]. Arabinose has been used as a 
carbon source for the production of organic acids [34] as well as for 
the production of the amino acids L-glutamate, L-lysine, L-ornithine 
and L-arginine [35]. 
 
As arabinose, the pentose sugar xylose is a component of 
lignocellulosic wastes. To funnel xylose into the pentose phosphate 
pathway, xylose has to be converted to xylulose and then 
phosphorylated to xylulose-5-phosphate. As C. glutamicum possesses 
a gene encoding a xylulokinase (xylB), the expression of the xylose 
isomerase gene (xylA) from E. coli was sufficient to enable growth 
from xylose as sole carbon source, but the additional expression of E. 
coli xylB accelerated growth of the recombinant C. glutamicum strain 
[36]. When optimizing arabinose utilization the arabinose 
transporter gene araE from C. glutamicum ATCC 31831 was 
expressed in the recombinant C. glutamicum xylose utilization strain, 
resulting in an increased xylose consumption rate and growth rate 
[34]. To prove its biotechnological usability, anaerobic production of 
succinic and lactic acid [36], as well as production of cadaverine [37] 
and the amino acids L-glutamate and L-lysine [38] from xylose was 
demonstrated. 
 
Cellobiose is contained in hydrolysates of cellulosic biomass. A 
C. glutamicum R mutant gained the ability to utilize cellobiose. This 
ability was due to mutations in the phosphotransferase permease 
subunit gene bglF, which is specific for the transport of the -
glucosides arbutin and salicin. Two mutations were published, both 
at the same position (317), resulting in amino acid exchanges from 
valine to alanine or methionine [39]. For the utilization of cellobiose 
also the phospho--glucosidase is needed (bglA). Both of these genes 
are present in C. glutamicum R, but are absent from others. Under 
oxygen deprivation conditions mixtures of cellobiose, glucose and 
xylose could be used for the production of lactic and succinic acid 
[34,40].  
 
Fast utilization of the dicarboxylic acids namely succinic, fumaric, 
and malic acid (intermediates of the tricarboxylic acid cycle) was 
observed only in spontaneous mutants, which showed increased 
expression levels of genes encoding proton- or sodium-dependent 
transporters DctA and DccT, respectively [41,42]. Increased 
expression was due to promoter-up mutations in the promoter 
regions of the genes. Overexpression of the corresponding genes dctA 
or dccT (dcsT in C. glutamicum R) resulted in fast growth with 
succinic, fumaric, and malic acid [41-43]. 
 
Metabolic engineering of C. glutamicum 
2 
Volume No: 3, Issue: 4, October 2012, e201210004 Computational and Structural Biotechnology Journal | www.csbj.org 
 
 
 
 
 
 
 
 
 
 
 
 
 
During the transesterfication process of oils and fats for biodiesel 
production, glycerol remains as a stoichiometric byproduct, with a 
yield of 100 kg per ton. Glycerol, previously an interesting product, 
also of biotechnology, became a waste material as the biodiesel 
industry arose. C. glutamicum, which cannot utilize glycerol 
naturally, was engineered for glycerol utilization by heterologous 
expression of the E. coli aerobic glycerol utilization genes encoding 
for a glycerol facilitator, glycerol kinase, and glycerol-3-phosphate 
dehydrogenase [44]. The plasmid borne expression of these genes 
enabled C. glutamicum for fast growth with glycerol as sole carbon 
source. When compared to glucose similar L-glutamate and L-lysine 
production properties were reached when using glycerol [44]. Using 
the same plasmid recently efficient succinic acid production from 
glycerol could be achieved [45]. 
 
Coutilization of substrates is a typical characteristic of C. 
glutamicum [14], and has been studied in detail with respect to the 
co-utilization of acetate and glucose [46,47]. Coutilization is 
advantageous in biotechnological applications, but it is absent in 
other hosts e.g. E. coli [48] or B. subtilis [49], which show successive 
utilization of substrates, carbon catabolite repression, and diauxic 
growth. But, no rule without exceptions: C. glutamicum does utilize 
glucose before L-glutamic acid or ethanol, and acetate before ethanol 
[50,51].  
Moreover, when additional carbon utilization pathways are 
introduced into C. glutamicum coutilization is pertinent and has been 
shown for utilization of glycerol with glucose [44], lignocellulose 
compound xylose with glucose [36], arabinose with glucose [35], 
xylose and arabinose with glucose [38], and cellobiose together with 
xylose and glucose [34].  
 
III. Metabolic engineering of C. glutamicum for product 
formation 
 
This section summarizes the wide array of metabolic products for 
which C. glutamicum has been engineered. The majority of these 
products are amino acids or organic acids but diamines, alcohols and 
other products of industrial relevance are being continuously added to 
this repertoire. As mentioned earlier, metabolic engineering of L-
glutamate  and  L-lysine will not be a part of this review because they  
Figure 1. Carbon source utilization in C. glutamicum. Open boxes: C. glutamicum enzymes, gray shaded boxes: enzymes from other organisms produced in C. 
glutamicum by heterologous expression. Abbreviations: Ara, arabinose; AraA, arabinose isomerase; AraB, ribulokinase; AraD, ribulose 5-phosphate 4-
epimerase; AraE, arabinose transporter; βgal, β-galactosidase; BglA, phospho-β-glucosidase; BglF*, cellobiose specific PTS; Cel-6-P, cellobiose-6-phosphate; 
DHAP, dihydroxyacetonephosphate; Fba, fructose-bisphosphate aldolase; Fbp, fructose-bisphosphatase; Frc-1,6-BP, fructose-1,6-bisphosphate; Frc-6-P, 
fructose-6-phosphate; Frc-1-P, fructose-1-phosphate; GalPW, galactose pathway; GAP, glyceraldehyde-3-phosphate; Glc-6-P, glucose-6-phosphate; Glc, 
glucose; Glk, ATP dependent glucokinase; GlpD, glycerol-3-phosphate dehydrogenase; GlpF, glycerol facilitator; GlpK, glycerol kinase; Gly-3-P, glycerol-3-
phosphate; IolT, inositol transporter, also accepting glucose; LacP, lactose permease; PfkA, 6-phosphofructokinase; PfkB, 1-phosphofructokinase; PpgK, 
polyphosphate dependent glucokinase; PtsF, fructose specific PTS; PtsG, glucose specific PTS; PtsS, sucrose specific PTS; Rbu-5-P, ribulose-5-phosphate; ScrB, 
sucrose-6-phosphate hydrolase; Suc-6-P, sucrose-6-phosphate; Tpi, triosephosphate isomerase; Xlu-5-P, xylulose-5-phosphate; XylA, xylose isomerase; XylB, 
xylulokinase.  
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Figure 2. Products for which C. glutamicum has been metabolically engineered. The products are depicted in rectangles and the enzymes involved in the 
biosynthesis pathway (bold arrows) are shown in ovals. The gene names for which the designation is not the same as enzyme name are mentioned separately 
next to ovals. Broken arrows represent multiple steps. argR (underlined) is a gene-encoding regulator of the arginine pathway. Abbreviations: 2-KIV, 2-
Ketoisovaleric acid; 3P-Gly, 3-phosphoglycerate; α-KG, α-Ketoglutaric acid; ADC, Aspartate decarboxylase; ADH, alcohol dehydrogenase; AHAIR, 
acetohydroxyacid isomeroreductase; AHAS, acetohydroxyacid synthase; AK, acetate kinase; AlaT, alanine aminotransferase; AraE, arabinose transporter; ArgF, 
L-ornithine carbamoyltransferase; Asp, aspartate, AvtA, valine-pyruvate aminotransferase; CadA, L-lysine decarboxylase; CoAT, acetyl-CoA:CoA transferase; 
DHAD, dihydroxyacid dehydratase; DHAP, dihydroxyacetonephosphate; Fba, fructose-bisphosphate aldolase; Frc-6-P, fructose-6-phosphate; Frc-1,6-BP, 
fructose-1,6-bisphosphate; GAD, glutamate decarboxylase; GAP, glyceraldehyde-3-phosphate; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; GDH, 
glutamate dehydrogenase; Glc-6-P, glucose-6-phosphate; GLF, glucose/fructose facilitator; GOGAT, glutamate-2-oxoglutarate aminotransferase; HDH, 
homoserine dehydrogenase; H-ser, homoserine; ICL, isocitrate lyase; IolT1, inositol transporter; KIVD, 2-ketoacid decarboxylase; KPHMT, ketopantoate 
hydroxymethyltransferase; LDH, lactate dehydrogenase; LeuCD, 3-isopropylmalate dehydratase; LysC, aspartate kinase; MDH, mannitol dehydrogenase; 
MDH´, malate dehydrogenase; MGS, methylglyoxal synthase; OAA, Oxaloacetate; PCx, pyruvate carboxylase; PDC, pyruvate decarboxylase; PDHC, pyruvate 
dehydrogenase complex; PEP, phosphoenolpyruvate; PEPC, phosphoenolpyruvate carboxylase; PGDH, 3-phosphoglycerate dehydrogenase; PQO, 
pyruvate:quinone oxidoreductase; PSAT, phosphoserine aminotransferase; Pgi, glucose-6-phosphate isomerase; PS, pantothenate synsthase; PSP, 
phosphoserine phosphatase; PTA, phosphotransacetylase; PYR, pyruvate; SDH, succinate dehydrogenase; SerDH, serine dehydratase; SHMT, serine 
hydroxymethyltransferase; SpeC, ornithine decarboxylase; TA, transaminase; Thr, threonine; ThrB, homoserine kinase; XR, xylose reductase 
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have already been extensively reviewed [7-12]. In many cases, the 
strategy for product metabolic engineering has evolved over time, 
making use of results from ongoing research in order to overcome the 
bottlenecks identified and to finally get the most promising strain. All 
pathways and their components used for the engineering of different 
products discussed in this section are drawn in figure 2 and hence a 
reference to the same figure will not be made while discussing each 
product. Readers are also recommended to refer to Table 1 of another 
review [52] for a summary of production parameters of different C. 
glutamicum production strains. 
 
 
L-valine is an essential amino acid with application in feed and 
pharmaceutical industry and has a demand of several hundred tons per 
year [9]. Production of L-valine by C. glutamicum has been 
demonstrated both aerobically and anaerobically. Blombach et al. were 
able to engineer an aerobic L-valine producer by starting with a first-
generation strain having an inactivated pyruvate dehydrogenase 
complex (PDHC) and overexpressing L-valine biosynthesis pathway 
genes ilvBNCE. In order to channel all pyruvic acid towards L-valine 
production, pqo encoding pyruvate:quinone oxidoreductase and pyc 
encoding pyruvate carboxylase were deleted. The former enzyme 
converts pyruvic acid to acetic acid and the latter converts it to 
oxaloacetic acid. Furthermore, to increase the flux via pentose 
phosphate pathway in order to meet the cofactor (NADPH) demand, 
pgi encoding phosphoglucose isomerase was also deleted (Fig. 2). The 
resulting strain produced 48 g l-1 L-valine in 90 hours in a growth 
decoupled manner during fed-batch fermentation [53].  
For anaerobic production, Hasegawa et al. engineered a C. 
glutamicum strain by deletion of ldh encoding lactate dehydrogenase 
to prevent lactic acid formation and overexpression of a modified 
ilvBNCD (feedback resistant acetohydroxyacid synthase (encoded by 
ilvN) and a modified acetohydroxy acid isomeroreductase (encoded 
by ilvC) with preference for NADH instead of NADPH). 
Additionally, to allow use of NH3 instead of glutamate as amino 
donor, a Lysinibacillus sphaericus leucine dehydrogenase gene (ilvE) 
was expressed in C. glutamicum to catalyze the final transamination 
step. This approach yielded a C. glutamicum capable of producing up 
to almost 230 g l-1 L-valine in 48 hours under oxygen deprivation 
conditions [54]. 
 
L-isoleucine belongs to the aspartate family of amino acids and 
finds applications in food and pharmaceutical industry. In addition 
to being relatively long, L-isoleucine biosynthesis pathway shares 
genes with L-valine and L-leucine pathways and hence is subject to 
tight genetic and feedback regulation at multiple steps. Accordingly, 
these steps have been the targets of metabolic engineering in order to 
overcome the regulation and allow higher carbon flux towards L-
isoleucine. An L-lysine producer was selected as a starting strain for 
L-isoleucine production because it has a high flux through the 
feedback resistant aspartate kinase (lysCfbr) reaction, which is the first 
step towards L-isoleucine formation from L-aspartate. Additionally 
leuCD was mutated which reduces formation of L-leucine as a 
byproduct. In this genetic background, chromosomal expression of 
three copies of homfbr, a single copy of ilvAfbr and overexpression of 
ilvAfbr on a multiple copy vector yielded a strain that produced up to 
21 g l-1 isoleucine via fed-batch fermentation [55]. homfbr encodes for 
a feedback-resistant homoserine dehydrogenase that catalyzes 
homoserine formation and its overexpression increases flux towards 
threonine, which is the precursor amino acid of L-isoleucine. ilvAfbr 
encodes for a feedback-resistant threonine dehydratase that catalyzes 
the first step in conversion of L-threonine to L-isoleucine. Upon 
investigation of another L-isoleucine producer it was also shown that 
L-isoleucine export, rather than precursor supply or enzyme activities, 
is the limiting factor in obtaining higher titers and therefore presents 
a prospective opportunity for further improvement.  
 
L-serine finds applications in pharmaceutical and cosmetic 
industry and is produced in the range of 300 tons per year [56]. It is 
degraded by C. glutamicum and holds a key position in central 
metabolism. Hence, mere overexpression of serine biosynthetic 
pathway genes serAΔ197 (made insensitive to feed-back regulation by 
truncation of 197 amino acids at C-terminus), serC and serB was not 
enough for serine production. serAΔ197 encodes for 3-
phosphoglycerate dehydrogenase (PGDH) [57] that catalyzes the 
first step of serine formation by converting the glycolysis 
intermediate 3-phosphoglycerate to hydroxypyruvate phosphate. serC 
and serB encode phosphoserine aminotransferase (PSAT) and 
phosphoserine phosphatase (PSP) respectively that are responsible 
for the next two steps resulting in L-serine formation. [56,58]. In 
addition to the overexpression of these L-serine biosynthesis pathway 
genes, a disruption of serine hydroxymethyltransferase gene (glyA) 
and serine dehydratase gene (sdaA), whose products are responsible 
for L-serine conversion to glycine and pyruvic acid respectively, was 
essential to form L-serine (9 g l-1) as a product [56,58]. 
 
L-arginine is the most abundant nitrogen carrier in animals and is 
essential for ammonia detoxification. Its clinical application in 
treatment of a variety of diseases including diabetes, AIDS and heart 
diseases has been reported [59]. Using reverse engineering, Ikeda et 
al., combined mutations identified in classical producers to engineer 
an L-arginine and L-citrulline producer. These mutations were found 
to be in the arginine repressor gene argR and in the argB gene whose 
product catalyzes the N-acetylglutamate kinase reaction in the 
beginning part of the arginine biosynthesis pathway [60]. 
Accordingly, argR was deleted and the two amino acid substitutions 
observed in classical producer (A26V and M31V) were introduced 
in the wild type N-acetylglutamate kinase resulting in higher 
productivity of L-arginine and L-citrulline at the suboptimal 
temperature of 38°C. However, this strain could not produce L-
arginine at the optimal temperature of 30°C. Later, Schneider et al., 
[35] starting with a similar strain carrying argR deletion and 
overexpressing a feedback resistant argB, created C. glutamicum 
ARG1 which led to production of about 7 g l-1 L-arginine at 30oC. 
Overexpression of the arabinose utilization operon araBAD (Fig. 1) 
in ARG1 allowed it to utilize arabinose or a mixture of glucose and 
arabinose as carbon source, resulting in production of about 8.3 g l-1 
L-arginine, although complete utilization of arabinose was not 
possible [35]. 
 
L-methionine belongs to the aspartate family of amino acids and 
is the third most-produced amino acid (tons per annum), next to L-
glutamate and L-lysine. However, so far, its fermentative production 
has not been proven to be industrially feasible. This is probably 
because with a requirement of 7 mol ATP and 8 mol NADPH per 
mol L-methionine, it is the most demanding amino acid for 
fermentative production. By deletion of a gene producing the 
competing amino acid L-threonine (thrB) and by deregulating 
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feedback inhibition of homoserine dehydrogenase (hom), Park et al, 
engineered a L-lysine producing C. glutamicum strain for production 
of 2.9 g l-1 L-methionine [61]. However, depletion of glucose in the 
medium led to disappearance of the produced L-methionine. 
Although not reflected in academic literature, commercial methionine 
fermentation could be a reality in the near future. 
 
L-ornithine is a non-proteinogenic amino acid that is an 
intermediate of the arginine biosynthesis pathway and might be used 
for treating liver diseases [62]. It was shown that deletion of argF 
gene encoding L-ornithine carbamoyltransferase to stop L-ornithine 
conversion and of argR encoding repressor of arginine biosynthesis 
pathway were sufficient for L-ornithine formation in C. glutamicum 
in milligrams per liter range [63]. Further optimization for L-arginine 
requirement of strains and introduction of arabinose utilization 
pathway (Fig. 1) resulted in L-ornithine titers of up to almost 26 g l-1 
in 72 hours using glucose and arabinose as a carbon source [35]. 
 
γ
γ-Aminobutyric acid (GABA) is a non-proteinogenic amino acid 
that functions as the main inhibitory neurotransmitter of the 
mammalian nervous system and has pharmaceutical relevance for use 
as anti-anxiety agent and in tranquilizers, diuretics and analgesics. It 
can be formed from glutamate via a single decarboxylation step and 
hence C. glutamicum, being a natural L-glutamate producer, can serve 
as a competitive production platform. Using heterologous expression 
of Lactobacillus brevis genes for: i) glutamate decarboxylase (gadB2) 
to catalyze glutamate decarboxylation to GABA, ii) L-
glutamate/GABA antiporter gene gadC and iii) the transcriptional 
regulator gene gadR, Shi and Li constructed a strain that could 
produce more than 2 g l-1 GABA in 72 hours [64]. Zhao et al. 
reported the GABA transporter in C. glutamicum responsible for its 
uptake and were able to show that disruption of its gene led to 
increased GABA production [65]. Production of GABA using C. 
glutamicum has the advantage that it is independent of external 
glutamate supply and complex media ingredients, which is the case 
when using lactic-acid bacteria (LAB) for its production. However 
the GABA production levels are higher using LAB and hence there is 
further need for improvement of C. glutamicum strains.  
 
Production of D-amino acids was also shown to be possible in C. 
glutamicum whereas other bacteria such as E. coli are sensitive to 
their presence even in low concentrations. Heterologous expression of 
Pseudomonas taetrolens racemase (argR) resulted in extracellular 
accumulation of equimolar amounts of L- and D- enantiomers of 
arginine, ornithine or lysine whereas D-serine concentration exceeded 
that of L-serine [66]. D-amino acids are used as building blocks in 
chemistry and hence their production via fermentation is of interest.  
 
 
Putrescine is a biogenic diamine that serves as a monomer in the 
production of polyamides e.g. nylons-4,6. Polyamides are produced 
on a multi-million-ton scale per annum predominantly from 
petrochemical routes and currently there is an increasing interest in 
their fermentative production. Putrescine can be formed via arginine- 
or ornithine decarboxylase pathways and it was shown that the latter 
results in better production levels [67]. The genetic engineering 
involved deletion of argF and argR in order to channel ornithine 
(putrescine precursor) solely towards putrescine and to relieve genetic 
repression of the arginine biosynthesis pathway respectively. 
Heterologous expression of the E. coli ornithine decarboxylase gene 
(speC) then led to formation of up to 6 g l-1 putrescine in 60 hours 
in a growth independent manner when supplemented with arginine 
[67]. In the next step, introduction of a plasmid addiction system 
expressing argF resulted in both relief of arginine auxotrophy and 
growth dependent putrescine production [68]. 
 
Like putrescine, cadaverine is also a diamine, which can be used 
for polyamide production [69]. Mimitsuka et al. were the first to 
engineer C. glutamicum for cadaverine production by replacing hom 
with the L-lysine decarboxylase gene cadA from E. coli, resulting in 
production of 2.6 g l-1 cadaverine from glucose in 18 hours [70]. 
hom deletion functioned to stop carbon flow downstream to the 
formation of branched chain amino acids (L-valine, L-leucine, L-
isoleucine) and diverted it instead towards cadaverine formation via 
lysine. In separate studies with different strains, expression of xylA 
and xylB that encode xylose utilization enzymes (Fig. 1) [37] and of 
amyA that encodes starch hydrolysis enzyme, (Fig. 1) [30] allowed 
cadaverine production from these substrates. Later on, overexpression 
of a putative permease, encoded by cg2893 [37] and deletion of a 
putative diaminopentane acetyltransferase, encoded by NCgl1469 
(cg1722) [37] were also shown to result in higher product formation 
and elimination of acetylated byproduct respectively. 
 
 
Succinic acid can serve as a platform chemical and hence there is 
plentiful research going on to produce it via fermentation [45,71-74]. 
The annual demand for the free acid is 15,000 tons whereas its salts 
are used annually in amounts up to 92,000 tons as deicers. For a 
feasible industrial process, the target succinic acid amount and 
productivity have been set at 150 g l-1 and 5 g l-1 h-1 respectively [75]. 
By deleting lactate dehydrogenase gene (ldhA) and overexpressing the 
anaplerotic pyruvate carboxylase gene (pyc), a C. glutamicum strain 
was made that produced 146 g l-1 succinic acid with a productivity of 
3.2 g l-1 h-1 under anaerobic conditions [73]. The former 
modification avoided lactic acid as byproduct and the latter drives the 
carbon flux in to the reductive tricarboxylic acid (TCA) cycle. In a 
pioneering study redox-balanced anaerobic succinate production 
could be achieved [72]. Besides the aforementioned modifications 
(overexpressing a modified pycP458S instead of wild type pyc) and 
deletion of all known acetic acid forming genes (cat, pqo, ackA-pta), 
overexpression of the glyceraldehyde 3-phosphate dehydrogenase 
(gapA) gene led to significantly reduced acetic acid (byproduct) 
formation, accelerated glucose consumption and very high succinic 
acid titers. Heterologous production of Mycobacterium vaccae 
formate dehydrogenase (fdh) entailed use of formate as cosubstrate 
[72]. Thus, coutilization of glucose with formate allowed for redox-
balanced anaerobic succinate production by this recombinant strain. 
Under aerobic conditions combined overexpression of 
phosphoenolpyruvate carboxylase (ppc) and pyruvate carboxylase 
(pyc) genes – to propel anaplerosis – and deletion of acetic acid 
forming genes (see above) and of succinic acid oxidizing genes 
(sdhCAB) – to prevent succinic acid conversion – resulted in a strain 
producing 10.6 g l-1 succinic acid in a growth decoupled manner. 
This is the highest titer reported for aerobic succinic acid production 
in C. glutamicum [74]. Subsequent overexpression of glycerol 
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utilization genes glpFKD (Fig. 1) allowed this strain to produce 
almost the same amount of succinic acid from glycerol [45]. 
 
Pyruvic acid finds applications in many industries including food, 
cosmetic and pharmaceutical. Production costs for chemical synthesis 
of pyruvate of US$ 8000-9000/ton have been reported [76]. Hence, 
there is a lot of interest in its fermentative production. It also holds 
an important position in the central carbon metabolism and serves as 
a connecting point between glycolysis and TCA cycle. Additionally, 
it is a branching point for the formation of a variety of organic and 
amino acids. Consequently, the approach for pyruvic acid engineering 
focused on attenuation of these ‘branches’ to allow for its 
accumulation. Acetyl-CoA, acetic acid, lactic acid and alanine 
production were minimized by deletion of pyruvate dehydrogenase 
(aceE), pyruvate:quinone oxidoreductase (pqo), lactate dehydrogenase 
(ldh) and of alanine aminotransferase (alaT) plus valine-pyruvate 
aminotransferase (avtA) genes respectively. Additionally, the C-
terminus of acetohydroxyacid synthase (AHAS) was deleted (ΔC-T 
ilvN) to prevent overflow metabolism into L-valine synthesis. Titers 
of more than 45 g l-1 were achieved using this strain [77]. 
 
Lactic acid is used in cosmetic and pharmaceutical industry. Its 
major market, however, is packaging where polymers of lactic acid are 
in demand. C. glutamicum wild type was shown to produce L-lactic 
acid under oxygen deprivation conditions and in fed-batch 
fermentation could produce 52 g l-1 L-lactic acid in 8 hours. In a 
continuous process using cell-recycling L-lactic acid production 
continued for 360 hours [78]. Succinic acid and acetic acid were also 
produced but only in lower amounts. 
A drawback associated with poly L-lactic acid (PLLA) is its low 
melting point. One way to improve this property is production of a 
stereocomplex of PLLA and Poly D-lactic acid. To engineer a strain 
that can produce D-lactic acid a L. delbrueckii D-lactate 
dehydrogenase gene was expressed in C. glutamicum with a deletion 
of the lactate dehydrogenase (ldhA) gene. The resulting strain 
produced 120 g l-1 of 99.9% optically pure D-lactic acid in less than 
30 hours [79].  
 
α
Like succinic acid, α-ketoglutaric acid is a TCA cycle 
intermediate and is in demand by pharmaceutical and food industry. 
Jo et al. engineered an α-ketoglutaric acid producer by starting with a 
L-glutamate producing strain as it already has a high α-ketoglutarate 
availability. Glutamate dehydrogenase and glutamate-2-oxoglutarate 
aminotransferase (GOGAT) encoding genes, gdh and gltB, 
respectively, were disrupted to abolish conversion of α-ketoglutaric 
acid to L-glutamate. In order to channel the precursor isocitrate 
solely to α-ketoglutaric acid, aceA encoding isocitrate lyase that 
converts isocitric acid into glyoxylic acid and succinic acid was also 
disrupted. The resulting triple mutant was able to accumulate 12.4 g 
l-1 α-ketoglutaric acid after 72 hours [80]. 
 
2-Ketoisovaleric acid (2-KIV) is used by pharmaceutical industry 
in drugs for treating kidney patients. It is a precursor of the amino 
acid L-valine and is formed from pyruvic acid in three reactions 
catalyzed by acetohydroxyacid synthase (AHAS, encoded by ilvBN), 
acetohydroxyacid isomeroreductase (AHAIR, encoded by ilvC) and 
dihydroxyacid dehydratase (DHAD encoded by ilvD). Accordingly, 
the engineering approach adopted by Krause et al. [81]involved 
overexpression of these biosynthetic pathway genes (ilvBNCD) in 
combination with deletion of: i) ilvE to prevent L-valine formation 
ii) aceE to channel pyruvate to 2-KIV formation and to allow growth 
decoupled production and iii) pqo to further enhance carbon flow to 
2-KIV synthesis. This resulted in the growth-decoupled formation of 
approximately 22 g l-1 2-KIV by the engineered C. glutamicum strain 
[81]. 
 
D-Pantothenic acid (Vitamin B5) can be synthesized by 
microorganisms and plants but not by animals and is therefore 
demanded as nutritional requirement for livestock and humans. Its 
worldwide market is reported to be 10,000 tons/year [82]. Starting 
from 2-ketoisovaleric acid, pantothenic acid can be synthesized in 
four enzymatic steps. The enzymatic reactions of the pantothenic 
acid biosynthesis pathway (starting from pyruvic acid) are also partly 
shared by the L-isoleucine and L-valine biosynthesis pathways. Its 
production was elucidated in a first-generation C. glutamicum 
production strain by overexpression of ketoisovaleric acid pathway 
genes (ilvBNCD) and of D-pantothenic acid biosynthesis pathway 
genes (panBC). To prevent L-isoleucine formation, ilvA was deleted 
[83]. This strain accumulated up to 1 g l-1 D-pantothenic acid. 
Metabolic analysis of this strain identified a high flux of the 
precursor 2-ketoisovaleric acid to L-valine instead of D-pantothenic 
acid as the main limitation for pantothenic acid production[84]. 
Using this information, a promoter down mutation was introduced 
in the first generation strain to attenuate ilvE expression and hence to 
stop L-valine formation. A duplication of panBC expression to 
increase flux into D-pantothenic acid formation was also done. This 
second-generation strain was able to attain titers of 1.75 g l-1 [85]. 
The precursor and other byproducts from associated pathways were 
still secreted by this strain indicating an opportunity for further 
metabolic engineering. 
 
 
Ethanol fermentation for use as fuel has a well-known history 
and ethanol production in USA alone was more than 13 billion 
gallons in 2010 [86]. Ethanol production was achieved in C. 
glutamicum by heterologous expression of the Zymomonas mobilis 
pyruvate decarboxylase gene (pdc) and overexpression of an alcohol 
dehydrogenase gene (adhB). The former enzyme catalyzes 
decarboxylation of pyruvic acid to acetaldehyde, which is in turn 
reduced by the latter enzyme to ethanol. Ethanol production was 
observed with these modifications but lactic acid and succinic acid 
were also produced as byproducts. Disruption of the lactate 
dehydrogenase (ldh) and phosphoenolpyruvate carboxylase (ppc) 
genes relieved this problem and the resulting strain produced about 
10 g l-1 ethanol under oxygen deprivation conditions [87]. 
Interestingly, C. glutamicum can well resist various growth inhibitors 
such as furans, phenols and acids that are formed during 
lignocellulose pretreatment under the chosen conditions, thereby 
opening up the prospect of ethanol production from biomass [88]. 
 
Recently, the research interest has shifted from ethanol 
fermentation to production of higher alcohols for use as biofuel due 
to various advantages offered by the latter such as higher energy 
density, compatibility with existing infrastructure and lower 
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corrosivity, vapor pressure and hygroscopicity. Isobutanol is one such 
higher alcohol and can be produced from 2-KIV in two steps. 
Because C. glutamicum has been successfully engineered for 
production of the isobutanol precursor 2-KIV [81] it appeared as a 
suitable organism for isobutanol production. Smith et al. engineered a 
producer strain by heterologous expression of a B. subtilis alsS, whose 
product (AHAS) catalyzes the conversion of pyruvic acid to 
acetolactate, in combination with the overexpression of ilvC and ilvD 
whose products in turn catalyze the next two steps towards 2-KIV 
formation. Heterologous expression of a Lactococcus lactis 2-
ketoacid decarboxylase gene (kivd) and overexpression of native 
alcohol dehydrogenase gene (adhA) then converted 2-KIV to 
isobutanol. pyc encoding pyruvate carboxylase (PCx) and ldh were 
deleted to direct more carbon through the isobutanol pathway. The 
resultant strain produced 4.9 g l-1 isobutanol in 120 hours [89]. 
Blombach et al achieved more than twofold higher titers after re-
engineering their 2-KIV producing strain for isobutanol 
biosynthesis[90]. Apart from deleting ldh, they also deleted a number 
of other genes to further increase pyruvic acid, 2-KIV and cofactor 
availability: aceE and pqo deletions served the first purpose, ilvE 
deletion the second and mdh deletion the third and last. However, 
the resultant strain grew very poorly on glucose. To overcome this 
drawback and to improve redox balance, E. coli pntAB operon 
encoding transhydrogenase was additionally expressed. This strain 
could then produce 13 g l-1 isobutanol under oxygen deprivation 
conditions [90]. 
 
1,2-propanediol holds a worldwide market of more than half 
million tons per annum and is used in food, cosmetic and 
pharmaceutical industries. Production of 1,2-propanediol by C. 
glutamicum was observed after heterologous expression of E. coli 
methylglyoxal synthase gene (mgs) and overexpression of a putative 
aldo-keto reductase gene (cgR_2242). The former enzyme catalyzes 
the conversion of the glycolytic intermediate dihydroxyacetone 
phosphate (DHAP) to methylglyoxal, which is reduced to 1,2-
propanediol by the latter enzyme. This approach resulted in a strain 
with a production capability of 1.8 g l-1 in 90 hours via fed-batch 
fermentation [91]. A high concentration of acetol, a 1,2-propanediol 
precursor, was also produced and presents a potential hurdle to reach 
higher 1,2-propanediol titers. 
 
 
D-Mannitol is used as an osmotic diuretic in pharmaceutical 
industry and as an alternative sweetener for diabetic patients in food 
industry and is produced using a chemical hydrogenation procedure. 
D-Mannitol production from D-fructose as substrate was 
demonstrated using resting cells of C. glutamicum [92]. The 
metabolic engineering steps included heterologous expression of: i) 
Leuconostoc pseudomesenteroides mdh, encoding a mannitol 
dehydrogenase, that catalyzes D-fructose to D-mannitol conversion, 
ii) Mycobacterium vaccae N10 fdh, encoding a formate 
dehydrogenase, that ensures ample cofactor supply in the presence of 
formate and iii) Z. mobilis glucose/fructose facilitator glf whose 
product enhances direct D-fructose uptake. The strain was able to 
form 285 g l-1 D-mannitol over a period of 96 hours using a fed-
batch approach [92]. Later on, the native transporters of C. 
glutamicum for D-fructose were identified and it was shown that 
overexpression of one of these (iolT1), instead of heterologous 
expression of glf, also resulted in increased D-fructose uptake rate 
[93]. 
 
Xylitol finds relevance in food industry where it is used as a 
dietetic sucrose alternative because it has one third the calories of 
sucrose while being equally sweet and can be produced directly from 
xylose via a single reduction step. The metabolic engineering for 
creating a C. glutamicum xylitol producer included: i) heterologous 
expression of a C. glutamicum ATCC31831 pentose transporter 
gene (araE), inserted into the chromosomal DNA to improve direct 
xylose uptake, ii) heterologous expression of a Candida tenuis gene 
encoding a single-site mutated xylose reductase (XR) to catalyze 
xylitol formation, iii) deletion of the lactate dehydrogenase gene (ldh) 
to allow use of cofactor utilized in lactic acid formation reaction for 
xylitol production instead, and iv) deletion of phosphoenolpyruvate-
dependent fructose phosphotransferase gene (ptsF) and xylulokinase 
gene (xylB) (Fig. 1) to prevent formation of xylitol-phosphate which 
is toxic for cells. The former enzyme catalyzes xylitol uptake via the 
phosphoenolpyruvate-dependent fructose phosphotransferase system 
and the latter is probably involved in its phosphorylation to yield the 
toxic intermediate. Indeed the deletion of these genes resulted in 
insensitivity to xylitol and enhanced xylitol productivity. The strain 
was shown to produce 166 g l-1 xylitol in 21 hours using resting cells 
and a fed-batch approach [94]. 
 
Cofactor availability is critical for biotransformation reactions as 
mentioned above for sugar alcohols. It has recently been shown that 
deletion of either 6-phosphofructokinase gene (pfkA) or 
glyceraldehyde 3-phosphate dehydrogenase gene (gapA) resulted in a 
higher NADPH per glucose yield as compared to wild-type strain, 
which could then be used for reductive biotransformation of the 
prochiral methyl acetoacetate to the chiral (R)-methyl 3-
hydroxybutyrate (MHB) via expression of a Lactobacillus brevis 
alcohol dehydrogenase. With this approach, an almost three fold 
increase of MHB yield could be observed. Deletion of these genes 
halts the flow through glycolysis, diverts it to pentose phosphate 
pathway (PPP) and generates a semi-cyclic (pfkA deletion) or cyclic 
(gapA deletion) PPP, resulting in an increased cofactor production 
and availability [95].  
 
IV. Summary and Outlook  
 
It is evident that currently there is plentiful research going on to 
metabolically engineer C. glutamicum: production of more than two-
third of the products discussed in this review has been made possible 
in the last four years only. The availability of the genome sequence 
and genetic engineering tools for this organism make its rapid and 
rational manipulation possible. So far, ‘omics’ technologies have not 
been extensively used in context of metabolic engineering of this 
bacterium, whereas they do hold the potential to elucidate production 
mechanisms and constraints on a systems-wide level. It can be 
expected that metabolic engineering of C. glutamicum will benefit 
from the increasing availability of gene sequences for pathway 
enzymes from many different organisms (not only E. coli and S. 
cerevisiae). In many cases, however, biochemical data rather than only 
a gene sequence are required to guide metabolic engineering and it is 
likely that more resources need to be directed towards physiological 
and biochemical experimental work. It is expected that pathway 
modeling, ideally in the context of a genome-scale metabolic model 
will contribute to metabolic engineering. Moreover, technical and 
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conceptual advances to gradually control expression of not one or 
two, but rather tens of genes will be required to install larger 
synthetic pathways. 
C. glutamicum is an attractive candidate for metabolic 
engineering as the biotechnological industry looks back at more than 
fifty years of safe production in the food and feed industry with this 
bacterium. Moreover, annual million-ton-scale production, such as of 
L-lysine and L-glutamate by C. glutamicum, cannot be overlooked. 
The examples described here demonstrate that C. glutamicum holds 
the potential as a general microbial production platform.  
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